Harnessing & Engineering the Therapeutic & Functional Delivery Capabilities of Extracellular Vesicles Through Optimized Characterization, Translation & Scale up Manufacturing for Accelerated Clinical Development

Among Our World-Class Speaker Faculty

speaker

Christopher Paradise

VP- Research & Development

Rion

speaker

Chulhee Choi

CEO

ILIAS Biologics

Speaker

Linda Marban

CEO

Capricor Therapeutics

Yushi Feng

VP- Regulatory Affairs

Codiak BioSciences

speaker

Joana Correia

CEO

Exogenus Therapeutics

Speaker

Michael Bellio

VP- Research & Manufacturing; Laboratory Director

Organicell

speaker

Steve Stice

CSO

Aruna Bio

Yushi Feng

VP- Regulatory Affairs

Codiak BioSciences

With 35+ pioneering speakers, join us in Boston to hear how they address the major challenges facing the industry:

Tune into How Companies are Innovating Characterization Strategies of EVs

Unraveling emerging characterization as a method for understanding product heterogeneity and structure-activity relationship in EVs and advancing proteomics on exosomes to improve protein identification with insights from Codiak BioScience, Aegle Therapeutics & Florica Therapeutics

Optimize the Latest Advancements of Functional Cargo Delivery

Unlocking insights in payload delivery and cargo loading of EVbased neural stem cells in CNS and in engineered exosomes as gene delivery tools for the treatment of glioblastoma. Hear from research institutes and companies like the MD Anderson Cancer Center, Aurna Bio & ReNeuron Group

Overcoming Challenges of Large-Scale EV Manufacture & Successful Translational to Clinical Level

Deep dive into the latest technological approaches to advance isolation and purification of EVs towards scale-up manufacturing of clinical-grade material in a reproducible manner with insights from Oragnicell, Rion & Fralin Biomedical Research Institute at VTC

Explore the Current Pre-Clinical, Clinical Landscape & Future Directions of the EV Field Across Different Therapeutic Applications

Shining a spotlight on the therapeutic potential of engineered exosomes in inflammatory diseases and CNS disorders as well as novel exosome-based therapies for treating colorectal cancer with EV Therapeutics MdImmune & ILIAS Biologics

Gain Insight into the Regulatory Landscape to Accelerate Clinical Approval of EVs

Exploring considerations on regulatory CMC dossier preparation of EV- based therapeutics and outlining important regulatory considerations for accelerated clinical approvals with Codiak BioSciences & Rion

Proud to Partner With

lonza logo
RoosterBio Sponsor Logo
newlogo jpeg (002)
NIS Color Logo with Tagline
fujifilm logo
Other Events in the World RNA Series: